563 related articles for article (PubMed ID: 15601836)
1. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
2. Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors.
Lu C; Willingham MC; Furuya F; Cheng SY
Endocrinology; 2008 Jul; 149(7):3339-45. PubMed ID: 18356276
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone regulates the hypotriglyceridemic gene APOA5.
Prieur X; Huby T; Coste H; Schaap FG; Chapman MJ; Rodríguez JC
J Biol Chem; 2005 Jul; 280(30):27533-43. PubMed ID: 15941710
[TBL] [Abstract][Full Text] [Related]
4. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
6. Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression.
Amma LL; Campos-Barros A; Wang Z; Vennström B; Forrest D
Mol Endocrinol; 2001 Mar; 15(3):467-75. PubMed ID: 11222747
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
Watanabe G; Albanese C; Lee RJ; Reutens A; Vairo G; Henglein B; Pestell RG
Mol Cell Biol; 1998 Jun; 18(6):3212-22. PubMed ID: 9584162
[TBL] [Abstract][Full Text] [Related]
8. Essential Role of GATA2 in the Negative Regulation of Type 2 Deiodinase Gene by Liganded Thyroid Hormone Receptor β2 in Thyrotroph.
Matsunaga H; Sasaki S; Suzuki S; Matsushita A; Nakamura H; Nakamura HM; Hirahara N; Kuroda G; Iwaki H; Ohba K; Morita H; Oki Y; Suda T
PLoS One; 2015; 10(11):e0142400. PubMed ID: 26571013
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary.
Sadow PM; Koo E; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Seo H; Murata Y; Weiss RE
Mol Endocrinol; 2003 May; 17(5):882-94. PubMed ID: 12576486
[TBL] [Abstract][Full Text] [Related]
10. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
[TBL] [Abstract][Full Text] [Related]
11. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
12. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
[TBL] [Abstract][Full Text] [Related]
13. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance.
Miller LD; McPhie P; Suzuki H; Kato Y; Liu ET; Cheng SY
Genome Biol; 2004; 5(5):R31. PubMed ID: 15128445
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
[TBL] [Abstract][Full Text] [Related]
15. Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors.
Nygård M; Wahlström GM; Gustafsson MV; Tokumoto YM; Bondesson M
Mol Endocrinol; 2003 Jan; 17(1):79-92. PubMed ID: 12511608
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity.
Barrera-Hernandez G; Park KS; Dace A; Zhan Q; Cheng SY
Endocrinology; 1999 Nov; 140(11):5267-74. PubMed ID: 10537157
[TBL] [Abstract][Full Text] [Related]
18. Feedback on hypothalamic TRH transcription is dependent on thyroid hormone receptor N terminus.
Guissouma H; Dupré SM; Becker N; Jeannin E; Seugnet I; Desvergne B; Demeneix BA
Mol Endocrinol; 2002 Jul; 16(7):1652-66. PubMed ID: 12089358
[TBL] [Abstract][Full Text] [Related]
19. An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin production in thyrotropin-secreting pituitary tumors.
Gittoes NJ; McCabe CJ; Verhaeg J; Sheppard MC; Franklyn JA
Thyroid; 1998 Jan; 8(1):9-14. PubMed ID: 9492147
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors.
Lin HM; Zhao L; Cheng SY
J Biol Chem; 2002 Aug; 277(32):28733-41. PubMed ID: 12048199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
